Literature DB >> 29627773

Clinical outcome of Guillain-Barré syndrome after prolonged mechanical ventilation.

Bianca van den Berg1, Eline F Storm1, Marcel J P Garssen2, Patricia H Blomkwist-Markens3, Bart C Jacobs1,4.   

Abstract

BACKGROUND: Patients with Guillain-Barré syndrome (GBS) may suffer from respiratory failure for months or longer. The aim of this study was to determine the frequency, clinical course and outcome of patients with GBS requiring prolonged mechanical ventilation (MV).
METHODS: Prospectively collected data from 526 patients with GBS participating in previous trials were analysed to determine the frequency and duration of prolonged MV (longer than 2 months). In addition, a cross-sectional study was conducted in patients with GBS requiring MV to determine the clinical course and long-term outcome with the ability to walk unaided as primary endpoint.
RESULTS: In the cohort study, 145 of 526 patients with GBS (28%) required MV, including 33 (6%) patients with prolonged MV. Patients requiring prolonged MV had a lower Medical Research Council sum score and more frequent bulbar involvement and inexcitable nerves compared with shorter ventilated patients. At 6 months, 18% of patients with prolonged MV were able to walk unaided compared with 76% of patients requiring shorter MV (P<0.001). In the cross-sectional study, 63 patients requiring MV were included with a median follow-up of 11 years (range 2-44 years). Twenty-six (41%) of these patients needed prolonged MV (median 93 days, range 62-261). Fifteen (58%) of these patients were able to walk unaided at maximum follow-up and eight (31%) reached this endpoint more than 1 year after diagnosis.
CONCLUSIONS: Prolonged ventilation in GBS is associated with poor prognosis, yet patients requiring prolonged ventilation may show slow but persistent recovery for years and even reach the ability to walk and live independently. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  guillain-barre syndrome

Mesh:

Year:  2018        PMID: 29627773     DOI: 10.1136/jnnp-2018-317968

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Prolonged Ventilatory Support for Patients Recovering From Guillain-Barré Syndrome.

Authors:  Michael C F Cheng; Patrick B Murphy; Nicholas Hart; Matthew R B Evans; Jennifer E Spillane; Robin S Howard
Journal:  Neurol Clin Pract       Date:  2021-02

Review 2.  Diagnosis and management of Guillain-Barré syndrome in ten steps.

Authors:  Sonja E Leonhard; Melissa R Mandarakas; Francisco A A Gondim; Kathleen Bateman; Maria L B Ferreira; David R Cornblath; Pieter A van Doorn; Mario E Dourado; Richard A C Hughes; Badrul Islam; Susumu Kusunoki; Carlos A Pardo; Ricardo Reisin; James J Sejvar; Nortina Shahrizaila; Cristiane Soares; Thirugnanam Umapathi; Yuzhong Wang; Eppie M Yiu; Hugh J Willison; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2019-09-20       Impact factor: 42.937

3.  Guillain-Barré syndrome.

Authors:  Ario Mirian; Michael W Nicolle; Adrian Budhram
Journal:  CMAJ       Date:  2021-03-15       Impact factor: 8.262

4.  Effect of Electromyographic Biofeedback Therapy on Muscle Strength Recovery in Children with Guillain-Barré Syndrome.

Authors:  Qianqian Liu; Jianhua Xue; Pingping Zhao; Yue Ling; Suzhe Liu; Yakun Du; Ning Han; Mingxia Liu; Wei Di
Journal:  J Healthc Eng       Date:  2021-12-23       Impact factor: 2.682

5.  Risk Factors and Prognosis in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Requiring Prolonged Mechanical Ventilation.

Authors:  Jingfang Lin; Qu Xiang; Xu Liu; Jinmei Li
Journal:  Front Neurol       Date:  2022-02-09       Impact factor: 4.003

6.  Patients' attitude towards vaccination after Guillain Barré syndrome.

Authors:  Ben-Ole Holtz; Alexander Grimm; Hubertus Axer
Journal:  Health Sci Rep       Date:  2021-12-21

7.  Clinical Features and Outcome of the Guillain-Barre Syndrome: A Single-Center 11-Year Experience.

Authors:  Federica Ginanneschi; Fabio Giannini; Francesco Sicurelli; Carla Battisti; Giorgio Capoccitti; Sabina Bartalini; Andrea Mignarri; Nila Volpi; David Cioncoloni; Laura Franci; Nicola De Stefano; Alessandro Rossi
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

8. 

Authors:  Ario Mirian; Michael W Nicolle; Adrian Budhram
Journal:  CMAJ       Date:  2021-05-25       Impact factor: 8.262

9.  Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review.

Authors:  P De Sanctis; P E Doneddu; L Viganò; C Selmi; E Nobile-Orazio
Journal:  Eur J Neurol       Date:  2020-09-11       Impact factor: 6.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.